Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00645580
What this trial is testing

Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function

Who this might be right for
Schizophrenia
Sha'ar Menashe Mental Health Center 15
Not applicableStudy completedNCT00534222
What this trial is testing

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect

Who this might be right for
ManiaSchizophrenia
AstraZeneca 387
Not applicableStudy completedNCT02248987
What this trial is testing

Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

Who this might be right for
Schizophrenia
Seoul National University Hospital 36
Not applicableLooking for participantsNCT02640911
What this trial is testing

An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 3,000
Early research (Phase 1)Study completedNCT02634463
What this trial is testing

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

Who this might be right for
ImmunoassayAntipsychotic
Janssen Research & Development, LLC 81
Post-approval studies (Phase 4)Study completedNCT00205699
What this trial is testing

Metabolic Effects of Antipsychotics in Children

Who this might be right for
AggressionAttention Deficit-HyperactivityOppositional Defiant Disorder+2 more
Washington University School of Medicine 144
Not applicableWithdrawnNCT02363816
What this trial is testing

Beta-carotene and Oxidative Stress in Pediatric Second Generation Antipsychotic Use

Who this might be right for
Pediatric Population on Second Generation Antipsychotics
Wayne State University
Testing effectiveness (Phase 2)Study completedNCT00616798
What this trial is testing

RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
Hoffmann-La Roche 323
Post-approval studies (Phase 4)Study completedNCT00202293
What this trial is testing

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Melbourne Health 83
Post-approval studies (Phase 4)Study completedNCT00000373
What this trial is testing

Treatment of Obsessive-Compulsive Disorder

Who this might be right for
Obsessive-Compulsive Disorder
University of Florida 74
Not applicableUnknownNCT03708614
What this trial is testing

A Study Looking at How Well Children With Autism Spectrum Disorder on Medications Like Having More Protein

Who this might be right for
Autism Spectrum Disorder
Holland Bloorview Kids Rehabilitation Hospital 10
Large-scale testing (Phase 3)Study completedNCT01104792
What this trial is testing

Long-term Study of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 752
Post-approval studies (Phase 4)UnknownNCT01710163
What this trial is testing

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

Who this might be right for
Bipolar I Disorder
University of Sao Paulo 50
Testing effectiveness (Phase 2)WithdrawnNCT04761861
What this trial is testing

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

Who this might be right for
SchizophreniaDyslipidemias
Sadat City University
Large-scale testing (Phase 3)Study completedNCT00215254
What this trial is testing

Quetiapine in Social Anxiety Disorder

Who this might be right for
Social Anxiety Disorder
Duke University 15
Post-approval studies (Phase 4)Study completedNCT01527305
What this trial is testing

Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 212
Testing effectiveness (Phase 2)Study completedNCT03319953
What this trial is testing

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

Who this might be right for
Stable Schizophrenia
Neurocrine Biosciences 23
Post-approval studies (Phase 4)Study completedNCT02949752
What this trial is testing

Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile

Who this might be right for
Antipsychotics Weight Gain
Institute of Mental Health, Singapore 67
Post-approval studies (Phase 4)Study completedNCT01670019
What this trial is testing

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

Who this might be right for
Major Depressive Disorder Without Psychotic Features
Duke University 46
Post-approval studies (Phase 4)Study completedNCT00835107
What this trial is testing

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

Who this might be right for
Depression, Bipolar
Queen's University 14
Next Page